50 38

Cited 0 times in

Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α

Authors
 Jihye Park  ;  Jae Hee Cheon 
Citation
 KOREAN JOURNAL OF INTERNAL MEDICINE, Vol.37(5) : 895-905, 2022-09 
Journal Title
KOREAN JOURNAL OF INTERNAL MEDICINE
ISSN
 1226-3303 
Issue Date
2022-09
MeSH
Adrenal Cortex Hormones / adverse effects ; Humans ; Immunologic Factors / adverse effects ; Inflammatory Bowel Diseases* / drug therapy ; Mesalamine* / adverse effects ; Tumor Necrosis Factor Inhibitors ; Tumor Necrosis Factor-alpha
Keywords
Adrenal cortex hormones ; Anti-TNF agents ; Immunologic factors ; Inflammatory bowel diseases ; Mesalamine
Abstract
The incidence and prevalence of inflammatory bowel diseases (IBDs) are rapidly increasing worldwide. IBDs are considered an emerging problem not only in Western countries but also in developing counties. The relapses and complications of active IBD mandate various medications. Nevertheless, hospitalization, emergency room visits, or surgery may be required, resulting in a socioeconomic burden. Great advances have been made in the development of new therapeutic options for IBD to achieve induction and maintenance remission. Nevertheless, conventional therapy is still the mainstay in the treatment of IBD. This review article provides an update on recent advances in conventional therapies, including 5-aminosalicylates, corticosteroids, immunomodulators, and anti-tumor necrosis factor-α agents to treat IBD.
Files in This Item:
T202204760.pdf Download
DOI
10.3904/kjim.2022.132
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Park, Ji Hye(박지혜)
Cheon, Jae Hee(천재희) ORCID logo https://orcid.org/0000-0002-2282-8904
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/191961
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links